Patents by Inventor Ashwini GADKARI

Ashwini GADKARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137921
    Abstract: A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
    Inventors: Nitin Bhalachandra DHARMADIKARI, Yashoraj R. ZALA, Ashwini GADKARI
  • Publication number: 20200000803
    Abstract: A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Applicant: Sun Pharma Advanced Research Company Ltd.
    Inventors: Nitin Bhalachandra Dharmadikari, Yashoraj Zala, Ashwini Gadkari
  • Patent number: 10413543
    Abstract: A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: September 17, 2019
    Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
    Inventors: Nitin Bhalachandra Dharmadikari, Yashoraj Zala, Ashwini Gadkari
  • Publication number: 20170056401
    Abstract: A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
    Type: Application
    Filed: February 12, 2016
    Publication date: March 2, 2017
    Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
    Inventors: Nitin Bhalachandra DHARMADIKARI, Yashoraj ZALA, Ashwini GADKARI